| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |